Heart Disease News and Research

Latest Heart Disease News and Research

Maternal obesity and birth defects

Mothers of babies born with some structural birth defectsincluding missing limbs, malformed hearts and underdeveloped spinal cordsappear more likely to be obese prior to becoming pregnant than mothers whose children are born without such defects, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

7 Aug 2007

Caffeine may help older women protect their thinking skills

Caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology ®, the medical journal of the American Academy of Neurology.

7 Aug 2007

FDA approves maraviroc, an antiretroviral drug for use in adult HIV patients.

The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

7 Aug 2007

Short heart health programs improve life expectancy and reduce hospitalizations

Secondary prevention programs for coronary heart disease that contain less than 10 hours contact with health professionals and those provided by family doctors are just as effective in saving lives as more expensive, longer and more specialized hospital-based alternatives, according to cardiovascular researchers at the University of Alberta in Edmonton, Canada.

6 Aug 2007

Many heart attack patients still not getting emergency reperfusion

Far more of today's heart attack patients receive emergency angioplasty treatment or clot-busting drugs to re-open their clogged heart arteries than even a decade ago, a new study finds.

6 Aug 2007

Implantable artificial lung

The University of Michigan Medical School laboratory working to develop an implantable artificial lung that can serve as a bridge to lung transplantation is entering the home stretch.

6 Aug 2007

Emergency angioplasty use rises, but some patients still miss out

Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Michigan researchers.

6 Aug 2007

7-step guide to understanding tonsils and strep

Fifteen-year-old Kaci Jawegg's family knew the signs and symptoms all too well: It would start with itchy ears, followed by a sore and scratchy throat.

6 Aug 2007

Be aware! whispering stroke all too common

Scientists in the U.S. say some people experience subtle symptoms which are suggestive of a stroke without an actual stroke being diagnosed.

6 Aug 2007

New device to treat chronic congestive heart failure

As part of a 40-site national trial, researchers at UT Southwestern Medical Center are studying a new medical device designed to treat patients with chronic congestive heart failure.

3 Aug 2007

Unlocking proteins from their cellular shell

Applying physical stress to cells, researchers at the University of Pennsylvania have demonstrated that everyday forces can alter the structure of proteins tucked within cells, unfold them and expose new targets in the fight against disease.

3 Aug 2007

Study cautions against use of coronary CT angiography in children

Cardiac-gated CTA radiation doses can vary and be as high as 28.4 mSv (10 times the annual natural background radiation) in children, according to a recent study conducted by researchers from Duke University Medical Center in Durham, NC and Stanford University Medical Center in Palo Alto, CA.

3 Aug 2007

Screening improves detection of atrial fibrillation

Actively screening people aged 65 or over in the community improves the detection of atrial fibrillation (irregular heart rhythm), a major risk factor for stroke, finds a study published on bmj.com.

3 Aug 2007

Innovative gene therapy research for muscular dystrophy

A major grant of approximately $10 million from the National Institutes of Health will help investigators at Columbus Children's Research Institute (CCRI) at Columbus Children's Hospital learn more about strategies to treat muscular dystrophy, potentially leading to two new gene therapy approaches.

3 Aug 2007

Age is important in HRT use

Five years ago this summer the National Institutes of Health's stopped early a major portion of the Women's Health Initiative (WHI), a large and ambitious study to address the most common causes of death, disability and impaired quality of life in postmenopausal women.

3 Aug 2007

New diagnostic tool to detect infection-causing bacteria

Infection-causing bacteria can't hide from researchers at Northern Arizona University, who recently helped develop the first diagnostic tool to detect them.

3 Aug 2007

Integrated system, rapid transfer offers lifeline for heart attack victims

Heart attack patients received lifesaving treatment quickly when hospitals and communities used an integrated, rapid transfer system to get patients to a facility equipped to perform artery-opening procedures, according to a report in Circulation: Journal of the American Heart Association.

3 Aug 2007

Neck muscles could play a crucial role in controlling blood pressure, heart rate and breathing

A chance discovery in the lab has helped University of Leeds scientists to show how the treatment for a stiff neck could do wonders for your blood pressure.

3 Aug 2007

Insulin Resistance Syndrome could be key to preventing cardiovascular disease, cancer, diabetes and Alzheimer's

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer's Disease and more.

3 Aug 2007

Efalizumab effective in treatment of heavy psoriasis

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.

3 Aug 2007